JAY WINSTON: Open Payments
NPI 1164580015 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$51,114 in 316 payments from 20 companies in 2025. Trend: 2023 $42,434 · 2024 $45,832 · 2025 $51,114
Speaker / faculty: $22,556Honoraria: $19,100Food & beverage: $5,136Travel & lodging: $3,549Consulting: $560Education: $213
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 33 | $24,681 |
| Supernus Pharmaceuticals, Inc. | 54 | $22,964 |
| Otsuka America Pharmaceutical, Inc. | 25 | $573 |
| Lundbeck LLC | 23 | $399 |
| Vanda Pharmaceuticals Inc. | 33 | $362 |
| Axsome Therapeutics, Inc. | 24 | $256 |
| Almatica Pharma LLC | 13 | $217 |
| ABBVIE INC. | 13 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $205 |
| Collegium Pharmaceutical, Inc. | 12 | $192 |
Products named: AUSTEDO XR, Qelbree, REXULTI, FANAPT, Auvelity, LOREEV XR, VRAYLAR, TRINTELLIX.
Industry payments across WI — which companies pay providers there.
